Wound care: The role of advanced wound healing technologies

Journal of Vascular Surgery

Volumn 52, Issue 3 SUPPL., 2010, Pages 59S-66S

  Wu, Stephanie C ^a   Marston, William ^b   Armstrong, David G ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; DIABETIC FOOT; FIBROBLAST; FOOT ULCER; FUTUROLOGY; HUMAN; HYPERBARIC OXYGEN; PRIORITY JOURNAL; PUBLICATION; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; VACUUM ASSISTED CLOSURE; WOUND CARE; WOUND HEALING; ARTIFICIAL SKIN; PATHOPHYSIOLOGY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

DIABETIC FOOT; HUMANS; HYPERBARIC OXYGENATION; NEGATIVE-PRESSURE WOUND THERAPY; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SKIN, ARTIFICIAL; TREATMENT OUTCOME; WOUND HEALING;

EID: 77956247517     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.06.009     Document Type: Review

References (56)

1. V. Falanga Classifications for wound bed preparation and stimulation of chronic wounds Wound Repair Regen 8 2000 347 352
2. T.A. Mustoe, K. O'Shaughnessy, and O. Kloeters Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis Plast Reconstr Surg 117 7 Suppl 2006 35S 41S
3. W.A. Marston Dermagraft Diabetic Foot Ulcer Study Group Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycemia Ostomy Wound Manage 52 2006 26 28 30, 32 passim
4. D. Paquette, and V. Falanga Leg ulcers Clin Geriatr Med 18 2002 77 88 vi
5. A. Veves, V. Falanga, D.G. Armstrong, M.L. Sabolinski Apligraf Diabetic Foot Ulcer Study Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial Diabetes Care 24 2001 290 295
6. K.H. Lee Tissue-engineered human living skin substitutes: development and clinical application Yonsei Med J 41 2000 774 779
7. Y.M. Bello, A.F. Falabella, and W.H. Eaglstein Tissue-engineered skin Current status in wound healing Am J Clin Dermatol 2 2001 305 313
8. W.A. Marston Dermagraft, a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer Expert Rev Med Devices 1 2004 21 31
9. J. Mansbridge, K. Liu, R. Patch, K. Symons, and E. Pinney Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range Tissue Eng 4 1998 403 414
10. J. Mansbridge Skin substitutes to enhance wound healing Expert Opin Investig Drugs 7 1998 803 809
11. W.A. Marston, J. Hanft, P. Norwood, R. Pollak Dermagraft Diabetic Foot Ulcer Study Group The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial Diabetes Care 26 2003 1701 1705
12. J.R. Hanft, and M.S. Surprenant Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis J Foot Ankle Surg 41 2002 291 299
13. A.C. Browne, M. Vearncombe, and R.G. Sibbald High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft Ostomy Wound Manage 47 2001 44 49
14. B. Allenet, F. Pare, T. Lebrun, L. Carr, J. Posnett, and J. Martini Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the French context Diabetes Metab 26 2000 125 132
15. L. Zaulyanov, and R.S. Kirsner A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers Clin Interv Aging 2 2007 93 98
16. S.K. De, E.D. Reis, and M.D. Kerstein Wound treatment with human skin equivalent J Am Podiatr Med Assoc 92 1 2002 19 23
17. J.F. Trent, and R.S. Kirsner Tissue engineered skin: Apligraf, a bi-layered living skin equivalent Int J Clin Pract 52 1998 408 413
18. K.G. Donohue, P. Carson, M. Iriondo, L. Zhou, L. Saap, and K. Gibson Safety and efficacy of a bilayered skin construct in full-thickness surgical wounds J Dermatol 32 2005 626 631
19. H. Brem, J. Balledux, T. Bloom, M.D. Kerstein, and L. Hollier Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing Arch Surg 135 2000 627 634
20. D.J. Newton, F. Khan, J.J. Belch, M.R. Mitchell, and G.P. Leese Blood flow changes in diabetic foot ulcers treated with dermal replacement therapy J Foot Ankle Surg 41 2002 233 237
21. Introduction Healing chronic wounds: technologic solutions for today and tomorrow Adv Skin Wound Care 13 2 Suppl 2000 4 5
22. M. Edmonds European and Australian Apligraf Diabetic Foot Ulcer Study Group Apligraf in the treatment of neuropathic diabetic foot ulcers Int J Low Extrem Wounds 8 2009 11 18
23. J.S. Steinberg, M. Edmonds, D.P. Hurley Jr, and W.N. King Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers J Am Podiatr Med Assoc 100 2010 73 77
24. Molecule of the month: Apligraf living human skin equivalent Drug News Perspect 11 1998 43
25. K. Dolynchuk, P. Hull, L. Guenther, R.G. Sibbald, A. Brassard, and M. Cooling The role of Apligraf in the treatment of venous leg ulcers Ostomy Wound Manage 45 1999 34 43
26. B. Fagrell, G. Jorneskog, and M. Intaglietta Disturbed microvascular reactivity and shuntinga major cause for diabetic complications Vasc Med 4 1999 125 127
27. W.K. Redekop, J. McDonnell, P. Verboom, K. Lovas, and Z. Kalo The cost effectiveness of Apligraf treatment of diabetic foot ulcers Pharmacoeconomics 21 2003 1171 1183
28. A. Langer, and W. Rogowski Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers BMC Health Serv Res 9 2009 115
29. S.K. McCallon, C.A. Knight, J.P. Valiulus, M.W. Cunningham, J.M. McCulloch, and L.P. Farinas Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds Ostomy Wound Manage 46 2000 28 32 34
30. D.G. Armstrong, L.A. Lavery, P. Abu-Rumman, E.H. Espensen, J.R. Vazquez, and B.P. Nixon Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot Ostomy Wound Manage 48 2002 64 68
31. M.T. Eginton, K.R. Brown, G.R. Seabrook, J.B. Towne, and R.A. Cambria A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds Ann Vasc Surg 17 2003 645 649
32. P.A. Blume, J. Walters, W. Payne, J. Ayala, and J. Lantis Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial Diabetes Care 31 2008 631 636
33. D.G. Armstrong, and L.A. Lavery Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial Lancet 366 2005 1704 1710
34. J. Apelqvist, D.G. Armstrong, L.A. Lavery, and A.J.M. Boulton Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds Am J Surg 195 2008 782 788
35. D.P. Kuffler Hyperbaric oxygen therapy: an overview J Wound Care 19 2010 77 79
36. R.J. Goldman Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review PM R 1 2009 471 489
37. A. Abidia, G. Laden, G. Kuhan, B.F. Johnson, A.R. Wilkinson, and P.M. Renwick The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial Eur J Vasc Endovasc Surg 25 2003 513 518
38. M. Kalani, G. Jorneskog, N. Naderi, F. Lind, and K. Brismar Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers Long-term follow-up J Diabetes Complications 16 2002 153 158
39. P. Kranke, M. Bennett, I. Roeckl-Wiedmann, and S. Debus Hyperbaric oxygen therapy for chronic wounds Cochrane Database Syst Rev 2 2004 CD004123
40. R.E. Grolman, D.K. Wilkerson, J. Taylor, P. Allinson, and M.A. Zatina Transcutaneous oxygen measurements predict a beneficial response to hyperbaric oxygen therapy in patients with nonhealing wounds and critical limb ischemia Am Surg 67 2001 1072 1079 discussion 1080
41. C.E. Fife, C. Buyukcakir, G.H. Otto, P.J. Sheffield, R.A. Warriner, and T.L. Love The predictive value of transcutaneous oxygen tension measurement in diabetic lower extremity ulcers treated with hyperbaric oxygen therapy: a retrospective analysis of 1,144 patients Wound Repair Regen 10 2002 198 207
42. M. Londahl, P. Katzman, A. Nilsson, and C. Hammarlund Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes Diabetes Care 33 2010 998 1003
43. A.W. Chuck, D. Hailey, P. Jacobs, and D.C. Perry Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers Int J Technol Assess Health Care 24 2008 178 183
44. E.V. Badiavas, and V. Falanga Treatment of chronic wounds with bone marrow-derived cells Arch Dermatol 139 2003 510 516
45. J. Deng, B.E. Petersen, D.A. Steindler, M.L. Jorgensen, and E.D. Laywell Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation Stem Cells 24 2006 1054 1064
46. C. Fathke, L. Wilson, J. Hutter, V. Kapoor, A. Smith, and A. Hocking Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair Stem Cells 22 2004 812 822
47. K. McFarlin, X. Gao, Y.B. Liu, D.S. Dulchavsky, D. Kwon, and A.S. Arbab Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat Wound Repair Regen 14 2006 471 478
48. S.M. Bauer, L.J. Goldstein, R.J. Bauer, H. Chen, M. Putt, and O.C. Velazquez The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia J Vasc Surg 43 2006 134 141
49. E.V. Badiavas, D. Ford, P. Liu, N. Kouttab, J. Morgan, and A. Richards Long-term bone marrow culture and its clinical potential in chronic wound healing Wound Repair Regen 15 2007 856 865
50. V. Falanga, S. Iwamoto, M. Chartier, T. Yufit, J. Butmarc, and N. Kouttab Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds Tissue Eng 13 2007 1299 1312
51. D.L. Steed Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers Diabetic Ulcer Study Group J Vasc Surg 21 1995 71 78
52. A. Veves, P. Sheehan, and H.T. Pham A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers Arch Surg 137 2002 822 827
53. G.D. Gentzkow, S.D. Iwasaki, and K.S. Hershon Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers Diabetes Care 19 1996 350 354
54. P.R. Cavanagh, B.A. Lipsky, A.W. Bradbury, and G. Botek Treatment for diabetic foot ulcers Lancet 366 2005 1725 1735
55. D.G. Armstrong, and A.J. Boulton Pressure offloading and "advanced" wound healing: isn't it finally time for an arranged marriage? Int J Low Extrem Wounds 3 2004 184 187
56. H. Brem, J. Balledux, T. Sukkarieh, P. Carson, and V. Falanga Healing of venous ulcers of long duration with a bilayered living skin substitute: results from a general surgery and dermatology department Dermatol Surg 27 2001 915 919